No significant weaknesses identified
| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| BWAYBrainsWay Ltd. | 452.42M | 23.10 | 128.33 | 29.04% | 12.73% | 8.92% | 1.44% | 0.09 |
| INSPInspire Medical Systems, Inc. | 2.8B | 96.47 | 55.13 | 28.49% | 5.05% | 6.69% | 3.25% | 0.05 |
| TIVCTivic Health Systems, Inc. | 3.11M | 1.23 | -0.06 | -33.67% | -15.57% | -134.25% | ||
| COCHEnvoy Medical, Inc. | 19.42M | 0.67 | -0.45 | -28.8% | -104.75% | |||
| HSDTSolana Company | 128.03M | 3.10 | -0.72 | -19.25% | -393.59% | -6.89% | 0.01 | |
| NXLNexalin Technology, Inc. | 12.87M | 0.69 | -0.83 | 52.35% | -55.3% | -182.01% | ||
| CVRXCVRx, Inc. | 143.37M | 5.47 | -2.06 | 30.53% | -92.95% | -108.26% | 0.71 | |
| VANIVivani Medical, Inc. | 91.92M | 1.26 | -2.93 | -19.88% | 1.10 |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 6.8M | 11.52M | 11.14M | 16.4M | 23.1M | 22.06M | 29.66M | 27.18M | 31.79M | 41.02M |
| Revenue Growth % | 1.01% | 0.69% | -0.03% | 0.47% | 0.41% | -0.05% | 0.34% | -0.08% | 0.17% | 0.29% |
| Cost of Goods Sold | 1.47M | 2.43M | 2.6M | 3.59M | 5.13M | 5.06M | 6.6M | 7.13M | 8.31M | 10.44M |
| COGS % of Revenue | 0.22% | 0.21% | 0.23% | 0.22% | 0.22% | 0.23% | 0.22% | 0.26% | 0.26% | 0.25% |
| Gross Profit | 5.33M | 9.1M | 8.55M | 12.81M | 17.97M | 17M | 23.06M | 20.05M | 23.48M | 30.58M |
| Gross Margin % | 0.78% | 0.79% | 0.77% | 0.78% | 0.78% | 0.77% | 0.78% | 0.74% | 0.74% | 0.75% |
| Gross Profit Growth % | 0.96% | 0.71% | -0.06% | 0.5% | 0.4% | -0.05% | 0.36% | -0.13% | 0.17% | 0.3% |
| Operating Expenses | 9.84M | 11.17M | 15.16M | 17.92M | 26.45M | 21.83M | 28.06M | 32.73M | 28.44M | 29.19M |
| OpEx % of Revenue | 1.45% | 0.97% | 1.36% | 1.09% | 1.14% | 0.99% | 0.95% | 1.2% | 0.89% | 0.71% |
| Selling, General & Admin | 5.54M | 6.95M | 9.29M | 11.34M | 17.66M | 16M | 21.66M | 25.05M | 21.64M | 22M |
| SG&A % of Revenue | 0.81% | 0.6% | 0.83% | 0.69% | 0.76% | 0.73% | 0.73% | 0.92% | 0.68% | 0.54% |
| Research & Development | 4.1M | 3.79M | 5.34M | 6.16M | 7.88M | 5.82M | 6.39M | 7.68M | 6.67M | 7.19M |
| R&D % of Revenue | 0.6% | 0.33% | 0.48% | 0.38% | 0.34% | 0.26% | 0.22% | 0.28% | 0.21% | 0.18% |
| Other Operating Expenses | 200K | 426K | 523K | 427K | 916K | 0 | 0 | 0 | 133K | 0 |
| Operating Income | -4.5M | -2.07M | -6.61M | -5.11M | -8.48M | -4.83M | -5M | -12.68M | -4.96M | 1.39M |
| Operating Margin % | -0.66% | -0.18% | -0.59% | -0.31% | -0.37% | -0.22% | -0.17% | -0.47% | -0.16% | 0.03% |
| Operating Income Growth % | 0.38% | 0.54% | -2.2% | 0.23% | -0.66% | 0.43% | -0.04% | -1.54% | 0.61% | 1.28% |
| EBITDA | -3.89M | -1.42M | -5.54M | -3.89M | -5.68M | -3.21M | -3.31M | -11.15M | -3.62M | 3.16M |
| EBITDA Margin % | -0.57% | -0.12% | -0.5% | -0.24% | -0.25% | -0.15% | -0.11% | -0.41% | -0.11% | 0.08% |
| EBITDA Growth % | 0.44% | 0.64% | -2.9% | 0.3% | -0.46% | 0.43% | -0.03% | -2.37% | 0.68% | 1.87% |
| D&A (Non-Cash Add-back) | 611K | 649K | 1.07M | 1.23M | 2.79M | 1.62M | 1.69M | 1.53M | 1.34M | 1.77M |
| EBIT | -3.99M | -1.99M | -6.8M | -5.92M | -9.51M | -5.08M | -6.36M | -12.99M | -3.9M | 3.59M |
| Net Interest Income | -19K | -49K | -112K | -351K | -331K | -45K | 84K | 1.04M | 1.87M | 1.12M |
| Interest Income | 18K | 12K | 22K | 44K | 175K | 61K | 225K | 1.11M | 2.17M | 2.48M |
| Interest Expense | 37K | 61K | 134K | 395K | 506K | 106K | 141K | 68K | 298K | 1.36M |
| Other Income/Expense | 418K | -328K | -274K | -1.16M | -1.43M | -319K | -1.42M | -351K | 1.01M | 2.07M |
| Pretax Income | -4.09M | -2.4M | -6.88M | -6.27M | -9.91M | -5.15M | -6.42M | -13.03M | -3.95M | 3.46M |
| Pretax Margin % | -0.6% | -0.21% | -0.62% | -0.38% | -0.43% | -0.23% | -0.22% | -0.48% | -0.12% | 0.08% |
| Income Tax | 0 | 0 | 169K | 209K | 422K | 237K | 43K | 315K | 251K | 538K |
| Effective Tax Rate % | 1% | 1% | 1.02% | 1.03% | 1.04% | 1.05% | 1.01% | 1.02% | 1.06% | 0.84% |
| Net Income | -4.09M | -2.4M | -7.05M | -6.48M | -10.33M | -5.38M | -6.46M | -13.35M | -4.2M | 2.92M |
| Net Margin % | -0.6% | -0.21% | -0.63% | -0.4% | -0.45% | -0.24% | -0.22% | -0.49% | -0.13% | 0.07% |
| Net Income Growth % | 0.38% | 0.41% | -1.94% | 0.08% | -0.59% | 0.48% | -0.2% | -1.07% | 0.69% | 1.7% |
| Net Income (Continuing) | -4.09M | -2.4M | -7.05M | -6.48M | -10.33M | -5.38M | -6.46M | -13.35M | -4.2M | 2.92M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.56 | -0.34 | -0.96 | -0.78 | -1.00 | -0.48 | -0.42 | -0.86 | -0.26 | 0.18 |
| EPS Growth % | 0.39% | 0.39% | -1.82% | 0.19% | -0.28% | 0.52% | 0.13% | -1.05% | 0.7% | 1.69% |
| EPS (Basic) | -0.56 | -0.34 | -0.96 | -0.78 | -1.00 | -0.48 | -0.42 | -0.86 | -0.26 | 0.17 |
| Diluted Shares Outstanding | 7.23M | 7.25M | 7.38M | 8.32M | 10.25M | 11.23M | 15.58M | 16.49M | 16.58M | 17.38M |
| Basic Shares Outstanding | 7.23M | 7.25M | 7.38M | 8.32M | 10.25M | 11.23M | 15.58M | 16.49M | 16.58M | 16.98M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 14.86M | 13.11M | 17.89M | 13.48M | 28.83M | 24.3M | 65.45M | 58.09M | 55.47M | 79.67M |
| Cash & Short-Term Investments | 11.94M | 9.17M | 14.51M | 8.97M | 21.89M | 17.18M | 57.35M | 47.58M | 45.98M | 69.34M |
| Cash Only | 11.36M | 9.17M | 14.51M | 8.97M | 21.67M | 16.96M | 16.92M | 47.58M | 10.52M | 69.34M |
| Short-Term Investments | 585K | 0 | 0 | 0 | 221K | 221K | 40.43M | 0 | 35.47M | 0 |
| Accounts Receivable | 2.8M | 2.91M | 2.93M | 3.97M | 5.96M | 5.79M | 6.33M | 4.84M | 3.78M | 4.6M |
| Days Sales Outstanding | 150.24 | 92.23 | 95.83 | 88.46 | 94.11 | 95.81 | 77.93 | 65.06 | 43.41 | 40.9 |
| Inventory | 0 | 585K | 271K | 91K | 306K | 442K | 200K | 3.84M | 3.72M | 4.43M |
| Days Inventory Outstanding | - | 87.98 | 38.12 | 9.25 | 21.78 | 31.9 | 11.06 | 196.45 | 163.3 | 154.81 |
| Other Current Assets | 0 | 380K | 507K | 1.07M | 0 | 212K | 388K | 1.83M | 691K | 1.3M |
| Total Non-Current Assets | 7.38M | 6.85M | 9.14M | 10.12M | 9.91M | 9.71M | 10.29M | 6.39M | 7.51M | 14.65M |
| Property, Plant & Equipment | 7.33M | 6.82M | 7.09M | 7.63M | 15.23M | 9.55M | 9.33M | 5.35M | 5.79M | 11.95M |
| Fixed Asset Turnover | 0.93x | 1.69x | 1.57x | 2.15x | 1.52x | 2.31x | 3.18x | 5.08x | 5.49x | 3.43x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 16K | 9K | 18K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 34K | 24K | 2.03M | 2.5M | -5.32M | 163K | 954K | 766K | 1.72M | 1.64M |
| Total Assets | 22.24M | 19.96M | 27.03M | 23.6M | 38.74M | 34.01M | 75.73M | 64.48M | 62.97M | 94.32M |
| Asset Turnover | 0.31x | 0.58x | 0.41x | 0.69x | 0.60x | 0.65x | 0.39x | 0.42x | 0.50x | 0.43x |
| Asset Growth % | -0.14% | -0.1% | 0.35% | -0.13% | 0.64% | -0.12% | 1.23% | -0.15% | -0.02% | 0.5% |
| Total Current Liabilities | 4.9M | 4.39M | 6.13M | 8.34M | 6.72M | 6.8M | 9.07M | 8.14M | 9.76M | 15.35M |
| Accounts Payable | 944K | 810K | 1.63M | 2.24M | 1.32M | 781K | 1.1M | 1.12M | 758K | 2.87M |
| Days Payables Outstanding | 235.03 | 121.82 | 229.41 | 228.11 | 93.94 | 56.36 | 60.95 | 57.14 | 33.3 | 100.32 |
| Short-Term Debt | 127K | 810K | 0 | 750K | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 0 | 1000K |
| Other Current Liabilities | 2.72M | 1.46M | 2.88M | 2.12M | 1.93M | 1.68M | 2.12M | 2.92M | 4.07M | 2.72M |
| Current Ratio | 3.04x | 2.98x | 2.92x | 1.62x | 4.29x | 3.57x | 7.22x | 7.14x | 5.68x | 5.19x |
| Quick Ratio | 3.04x | 2.85x | 2.87x | 1.61x | 4.25x | 3.51x | 7.20x | 6.66x | 5.30x | 4.90x |
| Cash Conversion Cycle | - | 58.39 | -95.46 | -130.4 | 21.95 | 71.35 | 28.04 | 204.37 | 173.41 | 95.4 |
| Total Non-Current Liabilities | 4.45M | 5.28M | 8.18M | 8.31M | 7.8M | 7.58M | 9.34M | 10.94M | 11.63M | 16.66M |
| Long-Term Debt | 0 | 0 | 2.73M | 2.08M | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 243K | 254K | 254K | 239K | 4.8M |
| Deferred Tax Liabilities | 0 | 0 | 112K | 140K | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 4.45M | 5.28M | 5.34M | 6.09M | 5.45M | 5.56M | 5.93M | 6.02M | 6.08M | 2.43M |
| Total Liabilities | 9.35M | 9.68M | 14.31M | 16.65M | 14.52M | 14.38M | 18.41M | 19.08M | 21.39M | 32M |
| Total Debt | 127K | 810K | 2.73M | 2.83M | 414K | 672K | 754K | 488K | 471K | 5.62M |
| Net Debt | -11.23M | -8.36M | -11.78M | -6.13M | -21.26M | -16.29M | -16.17M | -47.09M | -10.05M | -63.72M |
| Debt / Equity | 0.01x | 0.08x | 0.21x | 0.41x | 0.02x | 0.03x | 0.01x | 0.01x | 0.01x | 0.09x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | 1.78x |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | -20.15x |
| Interest Coverage | -121.76x | -33.92x | -49.34x | -12.95x | -16.75x | -45.56x | -35.45x | -186.51x | -16.64x | 1.03x |
| Total Equity | 12.89M | 10.29M | 12.72M | 6.95M | 24.22M | 19.63M | 57.33M | 45.4M | 41.58M | 62.31M |
| Equity Growth % | -0.17% | -0.2% | 0.24% | -0.45% | 2.48% | -0.19% | 1.92% | -0.21% | -0.08% | 0.5% |
| Book Value per Share | 1.78 | 1.42 | 1.72 | 0.84 | 2.36 | 1.75 | 3.68 | 2.75 | 2.51 | 3.58 |
| Total Shareholders' Equity | 12.89M | 10.29M | 12.72M | 6.95M | 24.22M | 19.63M | 57.33M | 45.4M | 41.58M | 62.31M |
| Common Stock | 147K | 149K | 171K | 171K | 233K | 233K | 363K | 364K | 367K | 413K |
| Retained Earnings | -45.65M | -48.05M | -55.1M | -61.58M | -71.91M | -77.29M | -83.76M | -97.11M | -101.3M | -98.38M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -1.27M | -1.27M | -1.27M | -2.19M | -2.19M | 1.56M | -2.19M | -2.19M | -2.19M | -2.19M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -4.55M | -2.4M | -3.47M | -3.77M | -7.24M | -1.44M | 884K | -9.76M | 1.28M | 10.3M |
| Operating CF Margin % | -0.67% | -0.21% | -0.31% | -0.23% | -0.31% | -0.07% | 0.03% | -0.36% | 0.04% | 0.25% |
| Operating CF Growth % | -0.2% | 0.47% | -0.44% | -0.09% | -0.92% | 0.8% | 1.62% | -12.04% | 1.13% | 7.02% |
| Net Income | -4.09M | -2.4M | -7.05M | -6.48M | -10.33M | -5.38M | -6.46M | -13.35M | -4.2M | 2.92M |
| Depreciation & Amortization | 611K | 649K | 1.07M | 1.23M | 1.6M | 1.62M | 1.69M | 1.53M | 1.34M | 1.77M |
| Stock-Based Compensation | 1.42M | -420K | 1.03M | 710K | 1.26M | 799K | 1.89M | 1.47M | 381K | 1.42M |
| Deferred Taxes | 17K | 12K | 169K | 209K | 422K | 237K | 43K | 315K | 251K | 0 |
| Other Non-Cash Items | -419K | 334K | 230K | 763K | 1.95M | 1.12M | 2.66M | 1.72M | 1.88M | 1.8M |
| Working Capital Changes | -2.09M | -580K | 1.09M | -204K | -2.15M | 179K | 1.07M | -1.45M | 1.64M | 2.39M |
| Change in Receivables | -1.16M | -499K | -21K | -419K | -2.5M | -104K | -849K | 1.46M | 1.09M | -867K |
| Change in Inventory | -358K | 264K | 276K | -330K | 0 | 0 | -411K | -3.6M | -506K | -920K |
| Change in Payables | -437K | 137K | 310K | 859K | 175K | -552K | 289K | 0 | -327K | 2.12M |
| Cash from Investing | -1.78M | -393K | -2.45M | -1.14M | -2.45M | -2.46M | -42.22M | 42.17M | -37.41M | 30.31M |
| Capital Expenditures | -2.27M | -408K | -985K | -1.97M | -3.31M | -2.47M | -2.24M | 1.94M | -2.39M | -4.76M |
| CapEx % of Revenue | 0.33% | 0.04% | 0.09% | 0.12% | 0.14% | 0.11% | 0.08% | 0.07% | 0.08% | 0.12% |
| Acquisitions | - | - | - | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 2K | 5K | -2M | 1.01M | 0 | 0 | -39.98M | 0 | -35.02M | 35.08M |
| Cash from Financing | 514K | 570K | 11.11M | -265K | 22.47M | -1.03M | 41.52M | -1.55M | -1.03M | 18.26M |
| Debt Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - | - | - | - | - |
| Other Financing | 514K | 570K | -39K | -265K | -425K | -613K | -269K | -962K | -755K | 2.33M |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | -6.82M | -2.81M | -4.45M | -5.75M | -10.55M | -3.91M | -1.35M | -9.76M | -1.1M | 6.5M |
| FCF Margin % | -1% | -0.24% | -0.4% | -0.35% | -0.46% | -0.18% | -0.05% | -0.36% | -0.03% | 0.16% |
| FCF Growth % | -0.29% | 0.59% | -0.58% | -0.29% | -0.84% | 0.63% | 0.65% | -6.21% | 0.89% | 6.9% |
| FCF per Share | -0.94 | -0.39 | -0.60 | -0.69 | -1.03 | -0.35 | -0.09 | -0.59 | -0.07 | 0.37 |
| FCF Conversion (FCF/Net Income) | 1.11x | 1.00x | 0.49x | 0.58x | 0.70x | 0.27x | -0.14x | 0.73x | -0.31x | 3.53x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 125K |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Metric | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -28.71% | -20.68% | -61.32% | -65.87% | -66.26% | -24.56% | -16.79% | -25.99% | -9.65% | 5.62% |
| Return on Invested Capital (ROIC) | -4223.44% | -86.45% | -346.49% | -436.85% | -336.62% | -114.88% | -16.85% | -48.21% | -24.93% | 6.93% |
| Gross Margin | 78.44% | 78.94% | 76.72% | 78.11% | 77.8% | 77.07% | 77.75% | 73.77% | 73.86% | 74.56% |
| Net Margin | -60.1% | -20.8% | -63.29% | -39.51% | -44.71% | -24.41% | -21.79% | -49.12% | -13.2% | 7.12% |
| Debt / Equity | 0.01x | 0.08x | 0.21x | 0.41x | 0.02x | 0.03x | 0.01x | 0.01x | 0.01x | 0.09x |
| Interest Coverage | -121.76x | -33.92x | -49.34x | -12.95x | -16.75x | -45.56x | -35.45x | -186.51x | -16.64x | 1.03x |
| FCF Conversion | 1.11x | 1.00x | 0.49x | 0.58x | 0.70x | 0.27x | -0.14x | 0.73x | -0.31x | 3.53x |
| Revenue Growth | 101.18% | 69.47% | -3.29% | 47.12% | 40.89% | -4.52% | 34.46% | -8.36% | 16.96% | 29.04% |
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Other | - | - | - | - | 7.81M | 7.79M |
| Other Growth | - | - | - | - | - | -0.22% |
| USA | 20.64M | 19.33M | 26.09M | 21.22M | - | - |
| USA Growth | - | -6.33% | 34.99% | -18.67% | - | - |
| Europes | 1.35M | 1.85M | 2.03M | 1.75M | - | - |
| Europes Growth | - | 36.51% | 9.96% | -13.98% | - | - |
| Others | 845K | 730K | 1.38M | 15K | - | - |
| Others Growth | - | -13.61% | 89.45% | -98.92% | - | - |
| Israel | 267K | 150K | 149K | - | - | - |
| Israel Growth | - | -43.82% | -0.67% | - | - | - |
BrainsWay Ltd. (BWAY) has a price-to-earnings (P/E) ratio of 128.3x. This suggests investors expect higher future growth.
BrainsWay Ltd. (BWAY) reported $49.1M in revenue for fiscal year 2024. This represents a 13378% increase from $0.4M in 2012.
BrainsWay Ltd. (BWAY) grew revenue by 29.0% over the past year. This is strong growth.
Yes, BrainsWay Ltd. (BWAY) is profitable, generating $6.2M in net income for fiscal year 2024 (7.1% net margin).
BrainsWay Ltd. (BWAY) has a return on equity (ROE) of 5.6%. This is below average, suggesting room for improvement.
BrainsWay Ltd. (BWAY) generated $18.3M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.